Glaukos Total Assets 2014-2024 | GKOS

Glaukos total assets from 2014 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Glaukos total assets for the quarter ending December 31, 2024 were $0.975B, a 3.65% increase year-over-year.
  • Glaukos total assets for 2024 were $0.975B, a 3.65% increase from 2023.
  • Glaukos total assets for 2023 were $0.94B, a 6.18% decline from 2022.
  • Glaukos total assets for 2022 were $1.002B, a 4.51% decline from 2021.
Glaukos Annual Total Assets
(Millions of US $)
2024 $975
2023 $940
2022 $1,002
2021 $1,050
2020 $1,006
2019 $818
2018 $207
2017 $166
2016 $134
2015 $117
2014 $26
2013 $31
Glaukos Quarterly Total Assets
(Millions of US $)
2024-12-31 $975
2024-09-30 $927
2024-06-30 $920
2024-03-31 $933
2023-12-31 $940
2023-09-30 $949
2023-06-30 $957
2023-03-31 $973
2022-12-31 $1,002
2022-09-30 $1,008
2022-06-30 $1,031
2022-03-31 $1,052
2021-12-31 $1,050
2021-09-30 $1,064
2021-06-30 $1,044
2021-03-31 $1,023
2020-12-31 $1,006
2020-09-30 $995
2020-06-30 $996
2020-03-31 $780
2019-12-31 $818
2019-09-30 $307
2019-06-30 $302
2019-03-31 $228
2018-12-31 $207
2018-09-30 $191
2018-06-30 $171
2018-03-31 $163
2017-12-31 $166
2017-09-30 $153
2017-06-30 $146
2017-03-31 $138
2016-12-31 $134
2016-09-30 $129
2016-06-30 $124
2016-03-31 $116
2015-12-31 $117
2015-09-30 $118
2015-06-30 $128
2015-03-31 $28
2014-12-31 $26
2014-09-30 $0
2014-06-30 $0
2014-03-31 $0
2013-12-31 $31
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $5.567B $0.383B
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $187.725B 22.76
Intuitive Surgical (ISRG) United States $176.405B 80.93
Alcon (ALC) Switzerland $46.824B 31.12
Edwards Lifesciences (EW) United States $42.608B 27.66
IDEXX Laboratories (IDXX) United States $34.032B 39.36
IQVIA Holdings (IQV) United States $31.084B 17.20
DexCom (DXCM) United States $26.777B 41.39
Mettler-Toledo (MTD) United States $24.611B 28.69
STERIS (STE) Ireland $22.269B 25.47
Waters (WAT) United States $21.897B 31.05
SONOVA HOLDING (SONVY) Switzerland $17.380B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $14.612B 14.91
Hologic (HOLX) United States $13.861B 14.96
Sysmex ADR (SSMXY) Japan $11.941B 37.44
Penumbra (PEN) United States $10.300B 93.17
Globus Medical (GMED) United States $10.068B 23.31
Masimo (MASI) United States $9.002B 37.78
Teleflex (TFX) United States $6.407B 9.86
Integer Holdings (ITGR) United States $3.967B 22.27
PROCEPT BioRobotics (PRCT) United States $3.194B 0.00
Veracyte (VCYT) United States $2.311B 41.76
TransMedics (TMDX) United States $2.265B 66.61
Nihon Kohden (NHNKY) Japan $2.205B 12.06
LivaNova (LIVN) United Kingdom $2.135B 12.96
Elekta AB (EKTAY) Sweden $1.995B 17.93
Integra LifeSciences Holdings (IART) United States $1.698B 8.59
Alphatec Holdings (ATEC) United States $1.462B 0.00
Tandem Diabetes Care (TNDM) United States $1.274B 0.00
OPKO Health (OPK) United States $1.115B 0.00
Paragon 28 (FNA) United States $1.096B 0.00
Artivion (AORT) United States $1.034B 98.32
RxSight (RXST) United States $1.022B 0.00
Pulse Biosciences (PLSE) United States $0.990B 0.00
AxoGen (AXGN) United States $0.820B 0.00
IRadimed (IRMD) United States $0.667B 34.99
AVANOS MEDICAL, INC (AVNS) United States $0.659B 10.61
Mesa Laboratories (MLAB) United States $0.645B 14.09
ORTHOFIX MEDICAL INC (OFIX) United States $0.636B 0.00
OrthoPediatrics (KIDS) United States $0.598B 0.00
SiBone (SIBN) United States $0.596B 0.00
Beta Bionics (BBNX) United States $0.531B 0.00
Treace Medical Concepts (TMCI) United States $0.525B 0.00
Delcath Systems (DCTH) United States $0.425B 0.00
NeuroPace (NPCE) United States $0.400B 0.00
AngioDynamics (ANGO) United States $0.380B 0.00
Pacific Biosciences Of California (PACB) United States $0.351B 0.00
Semler Scientific (SMLR) United States $0.347B 7.37
ClearPoint Neuro (CLPT) United States $0.329B 0.00
CVRx (CVRX) United States $0.318B 0.00
Tactile Systems Technology (TCMD) United States $0.313B 16.73
Nevro (NVRO) United States $0.224B 0.00
Inogen (INGN) United States $0.192B 0.00
Accuray (ARAY) United States $0.184B 0.00
Alpha Tau Medical (DRTS) Israel $0.177B 0.00
LENSAR (LNSR) United States $0.166B 0.00
908 Devices (MASS) United States $0.158B 0.00
Spectral Diagnostics (EDTXF) Canada $0.147B 0.00
Lucid Diagnostics (LUCD) United States $0.135B 0.00
Anteris Technologies Global (AVR) Australia $0.131B 0.00
Sight Sciences (SGHT) United States $0.123B 0.00
KORU Medical Systems (KRMD) United States $0.117B 0.00
Rapid Micro Biosystems (RPID) United States $0.114B 0.00
Neuronetics (STIM) United States $0.112B 0.00
Monogram Orthopaedics (MGRM) United States $0.104B 0.00
Atossa Genetics (ATOS) United States $0.087B 0.00
InspireMD (NSPR) Israel $0.080B 0.00
Sensus Healthcare (SRTS) United States $0.078B 11.82
EDAP TMS S.A (EDAP) France $0.073B 0.00
Zomedica (ZOMDF) United States $0.057B 0.00
Hyperfine (HYPR) United States $0.056B 0.00
Microbot Medical (MBOT) United States $0.052B 0.00
EnVVeno Medical (NVNO) United States $0.046B 0.00
Vicarious Surgical (RBOT) United States $0.039B 0.00
Baird Medical Investment Holdings (BDMD) $0.034B 0.00
Precision Optics (POCI) United States $0.032B 0.00
Spectral AI (MDAI) United States $0.027B 0.00
Envoy Medical (COCH) United States $0.026B 0.00
DarioHealth (DRIO) United States $0.025B 0.00
NexGel (NXGL) United States $0.023B 0.00
Accelerate Diagnostics (AXDX) United States $0.018B 0.00
Adagio Medical Holdings (ADGM) United States $0.012B 0.00
PAVmed (PAVM) United States $0.012B 0.00
Biosig Technologies (BSGM) United States $0.010B 0.00
Ekso Bionics Holdings (EKSO) United States $0.010B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.008B 0.00
WORK Medical Technology Group (WOK) China $0.008B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.007B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Aspira Women's Health (AWH) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
ReShape Lifesciences (RSLS) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00